Autoimmune Disease Therapeutics Market 2027 Bys Drug Class, Distribution Channel and Geography | The Insight Partners

Autoimmune Disease Therapeutics Market to 2027 - Global Analysis and Forecasts bys Drug Class (Immunosuppressant's, Anti-Inflammatory Drugs, Corticosteroids, Nonsteroidal anti-inflammatory drugs, Biologics); Distribution Channel (Hospitals, Clinics, Drug Stores, Independent pharmacies) and Geography

Report Code: TIPRE00004583 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
The autoimmune diseases causes abnormally low activity or over activity of the immune system. The immune system attacks body's own tissues and cells. Autoimmune diseases decrease the body's ability to fight foreign agents, causing vulnerability to infections. The autoimmune diseases are more common in women than in men also it is a top reason for morbidity in U.S. According to the National institute of health approximately 50 million people in America suffer from the autoimmune diseases. Crohn's disease, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, systemic lupus erythematosus are some examples of autoimmune diseases.

MARKET DYNAMICS
The global market for autoimmune disease therapeutics is expected to have increasing growth in upcoming years. There are many factors which contribute in growth of market such as increasing prevalence of autoimmune disease and growing awareness in the people helps in growth of market. Also the increasing automation of laboratories leads to diagnosis of several diagnostic tests to generate fast and error free results which further fuels the market growth. However the high cost of treatment, inadequate funding to the developing countries, and non-availability of proper treatment affects the growth of market.

MARKET SCOPE
The "Global Autoimmune Disease Therapeutics Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of autoimmune disease therapeutics market with detailed market segmentation by drug class and distribution channel, and geography. The global autoimmune disease therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading autoimmune disease therapeutics market players and offers key trends and opportunities in the market

MARKET SEGMENTATION
The global autoimmune disease therapeutics market is segmented on the basis of drug class and distribution channel. Based on drug class, the market is segmented as immunosuppressant's, anti-inflammatory drugs, corticosteroids, nonsteroidal anti-inflammatory drugs, biologics. On the basis of distribution channel, the global autoimmune disease therapeutics market is segmented into hospitals, clinics, drug stores, independent pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global autoimmune disease therapeutics market based on various segments. It also provides market size and forecast estimates from year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The autoimmune disease therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting autoimmune disease therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the autoimmune disease therapeutics market in these regions.

MARKET PLAYERS
The reports cover key developments in the autoimmune disease therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from autoimmune disease therapeutics market are anticipated to lucrative growth opportunities in the future with the rising demand for autoimmune disease drug in the global market. Below mentioned is the list of few companies engaged in the autoimmune disease therapeutics market.

The report also includes the profiles of key autoimmune disease therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ag
  • Bayer Schering Pharma Ag
  • Biogen Idec Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly And Company
  • Abbott Laboratories
  • Genentech Inc.
  • Merck & Co. Inc.
  • Johnson & Johnson Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Autoimmune Disease Therapeutics Market - By Drug Class
1.3.2 Autoimmune Disease Therapeutics Market - By Distribution Channel
1.3.3 Autoimmune Disease Therapeutics Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. AUTOIMMUNE DISEASE THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. AUTOIMMUNE DISEASE THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. AUTOIMMUNE DISEASE THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. AUTOIMMUNE DISEASE THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. AUTOIMMUNE DISEASE THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. AUTOIMMUNE DISEASE THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. IMMUNOSUPPRESSANT'S
7.3.1. Overview
7.3.2. Immunosuppressant's Market Forecast and Analysis
7.4. ANTI-INFLAMMATORY DRUGS
7.4.1. Overview
7.4.2. Anti-Inflammatory Drugs Market Forecast and Analysis
7.5. CORTICOSTEROIDS
7.5.1. Overview
7.5.2. Corticosteroids Market Forecast and Analysis
7.6. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
7.6.1. Overview
7.6.2. Nonsteroidal anti-inflammatory drugs Market Forecast and Analysis
7.7. BIOLOGICS
7.7.1. Overview
7.7.2. Biologics Market Forecast and Analysis
8. AUTOIMMUNE DISEASE THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. DRUG STORES
8.5.1. Overview
8.5.2. Drug Stores Market Forecast and Analysis
8.6. INDEPENDENT PHARMACIES
8.6.1. Overview
8.6.2. Independent pharmacies Market Forecast and Analysis
9. AUTOIMMUNE DISEASE THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Autoimmune Disease Therapeutics Market Overview
9.1.2 North America Autoimmune Disease Therapeutics Market Forecasts and Analysis
9.1.3 North America Autoimmune Disease Therapeutics Market Forecasts and Analysis - By Drug Class
9.1.4 North America Autoimmune Disease Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Autoimmune Disease Therapeutics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Autoimmune Disease Therapeutics Market
9.1.5.1.1 United States Autoimmune Disease Therapeutics Market by Drug Class
9.1.5.1.2 United States Autoimmune Disease Therapeutics Market by Distribution Channel
9.1.5.2 Canada Autoimmune Disease Therapeutics Market
9.1.5.2.1 Canada Autoimmune Disease Therapeutics Market by Drug Class
9.1.5.2.2 Canada Autoimmune Disease Therapeutics Market by Distribution Channel
9.1.5.3 Mexico Autoimmune Disease Therapeutics Market
9.1.5.3.1 Mexico Autoimmune Disease Therapeutics Market by Drug Class
9.1.5.3.2 Mexico Autoimmune Disease Therapeutics Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Autoimmune Disease Therapeutics Market Overview
9.2.2 Europe Autoimmune Disease Therapeutics Market Forecasts and Analysis
9.2.3 Europe Autoimmune Disease Therapeutics Market Forecasts and Analysis - By Drug Class
9.2.4 Europe Autoimmune Disease Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Autoimmune Disease Therapeutics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Autoimmune Disease Therapeutics Market
9.2.5.1.1 Germany Autoimmune Disease Therapeutics Market by Drug Class
9.2.5.1.2 Germany Autoimmune Disease Therapeutics Market by Distribution Channel
9.2.5.2 France Autoimmune Disease Therapeutics Market
9.2.5.2.1 France Autoimmune Disease Therapeutics Market by Drug Class
9.2.5.2.2 France Autoimmune Disease Therapeutics Market by Distribution Channel
9.2.5.3 Italy Autoimmune Disease Therapeutics Market
9.2.5.3.1 Italy Autoimmune Disease Therapeutics Market by Drug Class
9.2.5.3.2 Italy Autoimmune Disease Therapeutics Market by Distribution Channel
9.2.5.4 Spain Autoimmune Disease Therapeutics Market
9.2.5.4.1 Spain Autoimmune Disease Therapeutics Market by Drug Class
9.2.5.4.2 Spain Autoimmune Disease Therapeutics Market by Distribution Channel
9.2.5.5 United Kingdom Autoimmune Disease Therapeutics Market
9.2.5.5.1 United Kingdom Autoimmune Disease Therapeutics Market by Drug Class
9.2.5.5.2 United Kingdom Autoimmune Disease Therapeutics Market by Distribution Channel
9.2.5.6 Rest of Europe Autoimmune Disease Therapeutics Market
9.2.5.6.1 Rest of Europe Autoimmune Disease Therapeutics Market by Drug Class
9.2.5.6.2 Rest of Europe Autoimmune Disease Therapeutics Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Autoimmune Disease Therapeutics Market Overview
9.3.2 Asia-Pacific Autoimmune Disease Therapeutics Market Forecasts and Analysis
9.3.3 Asia-Pacific Autoimmune Disease Therapeutics Market Forecasts and Analysis - By Drug Class
9.3.4 Asia-Pacific Autoimmune Disease Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Autoimmune Disease Therapeutics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Autoimmune Disease Therapeutics Market
9.3.5.1.1 Australia Autoimmune Disease Therapeutics Market by Drug Class
9.3.5.1.2 Australia Autoimmune Disease Therapeutics Market by Distribution Channel
9.3.5.2 China Autoimmune Disease Therapeutics Market
9.3.5.2.1 China Autoimmune Disease Therapeutics Market by Drug Class
9.3.5.2.2 China Autoimmune Disease Therapeutics Market by Distribution Channel
9.3.5.3 India Autoimmune Disease Therapeutics Market
9.3.5.3.1 India Autoimmune Disease Therapeutics Market by Drug Class
9.3.5.3.2 India Autoimmune Disease Therapeutics Market by Distribution Channel
9.3.5.4 Japan Autoimmune Disease Therapeutics Market
9.3.5.4.1 Japan Autoimmune Disease Therapeutics Market by Drug Class
9.3.5.4.2 Japan Autoimmune Disease Therapeutics Market by Distribution Channel
9.3.5.5 South Korea Autoimmune Disease Therapeutics Market
9.3.5.5.1 South Korea Autoimmune Disease Therapeutics Market by Drug Class
9.3.5.5.2 South Korea Autoimmune Disease Therapeutics Market by Distribution Channel
9.3.5.6 Rest of Asia-Pacific Autoimmune Disease Therapeutics Market
9.3.5.6.1 Rest of Asia-Pacific Autoimmune Disease Therapeutics Market by Drug Class
9.3.5.6.2 Rest of Asia-Pacific Autoimmune Disease Therapeutics Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Autoimmune Disease Therapeutics Market Overview
9.4.2 Middle East and Africa Autoimmune Disease Therapeutics Market Forecasts and Analysis
9.4.3 Middle East and Africa Autoimmune Disease Therapeutics Market Forecasts and Analysis - By Drug Class
9.4.4 Middle East and Africa Autoimmune Disease Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Autoimmune Disease Therapeutics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Autoimmune Disease Therapeutics Market
9.4.5.1.1 South Africa Autoimmune Disease Therapeutics Market by Drug Class
9.4.5.1.2 South Africa Autoimmune Disease Therapeutics Market by Distribution Channel
9.4.5.2 Saudi Arabia Autoimmune Disease Therapeutics Market
9.4.5.2.1 Saudi Arabia Autoimmune Disease Therapeutics Market by Drug Class
9.4.5.2.2 Saudi Arabia Autoimmune Disease Therapeutics Market by Distribution Channel
9.4.5.3 U.A.E Autoimmune Disease Therapeutics Market
9.4.5.3.1 U.A.E Autoimmune Disease Therapeutics Market by Drug Class
9.4.5.3.2 U.A.E Autoimmune Disease Therapeutics Market by Distribution Channel
9.4.5.4 Rest of Middle East and Africa Autoimmune Disease Therapeutics Market
9.4.5.4.1 Rest of Middle East and Africa Autoimmune Disease Therapeutics Market by Drug Class
9.4.5.4.2 Rest of Middle East and Africa Autoimmune Disease Therapeutics Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Autoimmune Disease Therapeutics Market Overview
9.5.2 South and Central America Autoimmune Disease Therapeutics Market Forecasts and Analysis
9.5.3 South and Central America Autoimmune Disease Therapeutics Market Forecasts and Analysis - By Drug Class
9.5.4 South and Central America Autoimmune Disease Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Autoimmune Disease Therapeutics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Autoimmune Disease Therapeutics Market
9.5.5.1.1 Brazil Autoimmune Disease Therapeutics Market by Drug Class
9.5.5.1.2 Brazil Autoimmune Disease Therapeutics Market by Distribution Channel
9.5.5.2 Argentina Autoimmune Disease Therapeutics Market
9.5.5.2.1 Argentina Autoimmune Disease Therapeutics Market by Drug Class
9.5.5.2.2 Argentina Autoimmune Disease Therapeutics Market by Distribution Channel
9.5.5.3 Rest of South and Central America Autoimmune Disease Therapeutics Market
9.5.5.3.1 Rest of South and Central America Autoimmune Disease Therapeutics Market by Drug Class
9.5.5.3.2 Rest of South and Central America Autoimmune Disease Therapeutics Market by Distribution Channel
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. AUTOIMMUNE DISEASE THERAPEUTICS MARKET, KEY COMPANY PROFILES
11.1. AMGEN INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. F. HOFFMANN-LA ROCHE AG
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BAYER SCHERING PHARMA AG
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BIOGEN IDEC INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BRISTOL-MYERS SQUIBB COMPANY
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ELI LILLY AND COMPANY
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ABBOTT LABORATORIES
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. GENENTECH INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MERCK & CO. INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. JOHNSON & JOHNSON INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Amgen Inc.
2. F. Hoffmann-La Roche Ag
3. Bayer Schering Pharma Ag
4. Biogen Idec Inc.
5. Bristol-Myers Squibb Company
6. Eli Lilly And Company
7. Abbott Laboratories
8. Genentech Inc.
9. Merck & Co. Inc.
10. Johnson & Johnson Inc.